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Previews
tungstate, which can be considered a phosphate analog.FHA: A Signal Transduction Domain
The discussion was further extended to possible biologi-with Diverse Specificity cal functions of FHA domains. While such discussions
are useful, they are based on papers published up toand Function
2000. The field has been evolving rapidly and important
new information has been reported in several papers
published in 2001 and 2002. An updated discussion in-
The structure of the FHA domain of the Chfr mitotic corporating these new publications is provided below,
checkpoint protein described in this issue of Structure since they point to new insights that are relevant to
represents one of only a few known structures of this future studies of FHA domains, including the one from
newly discovered phosphoprotein binding domain Chfr.
with diverse function and specificity. First, the ligand specificity of FHA domains appears
to be more complicated and more diverse than other
The function of a forkhead-associated (FHA) domain known phosphoprotein binding domains. It has been
in recognizing phosphoproteins was first suggested in shown to bind phosphothreonine peptides [6, 7], phos-
1998 [1], and the structure of an FHA domain (the FHA2 photyrosine peptides [2, 8], as well as unphosphorylated
from yeast Rad53) was first solved by NMR in 1999 [2]. peptides [9]. Structures of several FHA-phosphopeptide
Now, the paper by Stavridi et al. [3] describes the crystal complexes have been reported. The consensus se-
structure of the FHA domain of the Chfr mitotic check- quences appear to differ for these types of ligands. The
point protein. While the overall fold of the Chfr FHA diversity also differs for different FHA domains. For ex-
domain is similar to the other FHA domains in that it ample, the C-FHA domain of yeast Rad53 binds both
consists of a sandwich of 11  strands, the present pT and pY peptides, whereas the N-FHA domain from
structure has a unique feature in that it forms a segment- Rad53 binds only pT peptides, and the FHA domain of
swapped dimer. In this structure, the last four  strands Chk2 binds both pT peptides and unphosphorylated
from the C terminus of one molecule replaces the corre- peptides. It will be interesting to see how the ligand
sponding segment of another molecule. This is possible specificity of the Chfr FHA domain compares with that
because the Chfr FHA domain contains a longer  of other FHA domains.
strand, designated 7/8, which is a combination of two Second, FHA domains from different proteins appear
 strands (7 and 8) in other FHA domains. Although to use the same set of residues to bind the phosphate
in all published structural studies the FHA domain exists group, even when the phospholigand is different. This
as a monomer, two recent papers report that the FHA binding mode is also conserved in the Chfr FHA complex
domain from human Chk2 protein forms oligomers in an with tungstate. On the other hand, the residues involved
autophosphorylation-dependent way [4, 5]. This oligo- in the binding of the rest of the peptide appear to be
merization increases after DNA damage in vivo, and different. The structural basis for the detailed interac-
involves the FHA domain from one Chk2 molecule and tions between different FHA domains and different
the phosphorylated SQ/TQ domain from another Chk2 phosphopeptides has been addressed [6–9]. There have
molecule. In view of these new findings, the structural been suggestions to classify FHA domains as different
or functional implication of the domain-swapped dimer classes on the basis of their ligand specificity or on the
of the Chfr FHA domain is potentially interesting and basis of the FHA residues involved in ligand binding. In
warrants further in-depth investigation. view of the new finding described above, such analyses
The biological functions of FHA-containing proteins and classification could be premature until more data
are very diverse. There are 51 FHA domains from H. are available.
sapiens listed in the Small Modular Architecture Re- Third, unlike SH2 domains, the consensus sequences
search Tool (SMART) database (http://smart.embl- deduced from binding analyses with combinatorial li-
heidelberg.de/), and there are many more in other organ- braries differ from the exact sequence of the binding
isms, including prokaryotes and eukaryotes. Many of site deduced from recent biological studies [10]. This
these proteins are involved in pathways of cell cycle finding suggests that the interaction between FHA and
control. Chfr is a mitotic checkpoint gene that functions its target phosphoprotein involves a large number of
in early mitosis to delay progression through prophase residues, possibly a surface, instead of only a few local-
in response to mitotic stress. While it is almost certain ized residues. Thus, the most desirable information to
that the FHA domain of the Chfr protein recruits a phos- be obtained in the future will be crystal structures of
phoprotein required for its biological function, the iden- the complexes between an FHA domain and its target
tity of the phosphoprotein(s) is unknown. The hope is phosphoprotein, rather than just a phosphopeptide. It
that structural studies will help to identify the ligand and is certain that many labs are working toward this goal.
provide insight into the specificity of the interaction,
which will in turn help to identify the biological target of
this FHA domain. Ming-Daw Tsai
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100 amino acids folds into an / structure with three
helices, helices A, B, and C. A catalytic lysine, Lys 72,
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Another Twist in Helix C
and a Missing Pocket is present in the N-terminal domain, and in the active
structure of PKA forms an ion pair with Glu 91 in helix
C. The C-terminal domain is largely helical, and houses
most of the known catalytic residues. It also possessesPKB/Akt reveals a major role for helix C in the regula-
the “activation loop,” where phosphorylation sites aretion of activity in the first structure of an AGC family
found. In PKA, Thr 197 of the activation loop is phosphor-protein kinase in its low-activity form.
ylated. The activation loop and helix C on the N-terminal
domain are in contact because helix C possesses one
It has been over a decade since the first structure of a of the ligands for the phosphothreonine (His 87). In PKA,
protein kinase was reported, that of PKA [1], a member a 30-residue tail crosses back to the N-terminal domain,
of the AGC family (cAMP-dependent, cGMP-dependent, and the last few residues (FTEF) fill a deep pocket be-
and PKC) [2]. PKA was solved in its phosphorylated tween helix C and the N-terminal domain  sheet (see
active form, revealing the interactions of the phosphory- Figure). This pocket is formed in the AGC kinases by
lation site threonine as well as the shape of the active the unique helix B, which displaces helix C from the 
kinase. To better understand the structural basis of the sheet.
activation event, one would like to compare the struc- To obtain the structure of the low-activity form of PKB,
tures of protein kinase in the low- and high-activity the FxxF motif and activating phosphorylation site at
states. Now, in the June issue of Molecular Cell, the Ser 474 (as well as the PH domain) were eliminated from
structure of PKB/Akt, another AGC family member, has the construct [3]. The most interesting feature of the
been solved in the low-activity form, making such a resulting structure is what is missing from the structure:
comparison possible [3]. the C terminus of helix B, and two turns of helix C;
While belonging to the same family, PKB/Akt has residues Ala 189 and Thr 197 (corresponding to Val 80
some unique properties. PKB can be activated by the to Thr 88 of PKA) are disordered and therefore not visible
combined actions of PDK1 (3-phosphoinositide-depen- in the structure. In addition, Glu 200 (Glu 91 of PKA) of
dent protein) and the second messenger PtdIns(3,4,5)P3, helix C is present in the structure of PKB, but does not
and has numerous substrates including kinase GSK-3, make a hydrogen bond to Lys 181 (Lys 72 of PKA), known
PFK2, and mTOR. It is also thought to have a prosurvival to be required for catalysis. Because of the disorder of
role, since a viral homolog (v-Akt) is an oncogene in the helices B and C, the binding pocket for the FxxF motif
transforming murine leukemia virus. is not present. Yang et al. demonstrate that binding
The domain structure and regulation of PKB is more of peptides corresponding to the FxxF motif in trans
complex than that of PKA. PKB possesses a PH domain activated PKB. Interestingly, the most potent peptide
which targets it to the plasma membrane in the presence was derived from a substrate of PDK1 that also contains
of PtdIns(3,4,5)P3, where it can become phosphorylated an FxxF motif [4] and a phosphorylation site. Thus, it is
by PDK1. Like PKA, PKB is regulated by phosphorylation likely that the FxxF motif is required to properly form
on a threonine residue in the activation loop (Thr 309). helices B and C and make an active enzyme.
In addition, it is activated by phosphorylation of a serine The activation loop between Leu 297 and Gln 312
residue in the C-terminal tail of the kinase (Ser 474). This (between the DFG and the catalytic threonine Thr 201
serine is well conserved in several AGC family members in PKA) in the PKB structure is also disordered. Changes
and directly follows a hydrophobic motif (FxxF) that is in conformation and order-disorder transitions in the
also highly conserved. PKA has the FxxF motif, but the activation loop are common in protein kinases, but that
sequence terminates there and it lacks the phosphoryla- it occurs in AGC kinases was unknown. In the AGC
tion site. kinases it is clear that helix C acts in concert with the
activation loop, since it houses one of the ligands toPKA has two domains. An N-terminal domain of about
